Is the FDA Too Cozy With Drug Companies?

A new report look at the “revolving door” between the FDA and drug companies

People who work at the U.S. Food and Drug Administration (FDA) as medical reviewers are responsible for parsing the risks and benefits of a particular drug before it gets the agency’s approval. But a new report from two researchers at the Oregon Health and Science University, order published in the journal The BMJ, cialis suggests many of these medical reviewers go on to work for the drug companies they oversaw while working for the government.

Critics have called out this revolving door between the FDA and the pharmaceutical industry, health and the study’s authors wanted to see how the numbers matched up to that claim. They looked at the FDA’s list of haematology-oncology drug approvals from 2006 to 2010 and scanned all medical reviews from 2001 to 2010 in the agency’s database, then looked up the subsequent jobs of the people who worked as medical reviewers for those drug approvals.

Read Full Article Here >>